<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://lipidbank.jp/mediawiki/index.php?action=history&amp;feed=atom&amp;title=LBF20207PG58</id>
	<title>LBF20207PG58 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://lipidbank.jp/mediawiki/index.php?action=history&amp;feed=atom&amp;title=LBF20207PG58"/>
	<link rel="alternate" type="text/html" href="https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG58&amp;action=history"/>
	<updated>2026-04-30T17:21:48Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG58&amp;diff=53110&amp;oldid=prev</id>
		<title>Editor at 08:42, 21 October 2010</title>
		<link rel="alternate" type="text/html" href="https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG58&amp;diff=53110&amp;oldid=prev"/>
		<updated>2010-10-21T08:42:49Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 17:42, 21 October 2010&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l6&quot;&gt;Line 6:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidBank=XPR1762&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidBank=XPR1762&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidMaps=LMFA03010080&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidMaps=LMFA03010080&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|SysName=(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (5-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;cis,&lt;/del&gt;13&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-trans&lt;/del&gt;) -dien-1-oic acid&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|SysName=(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;cis-&lt;/ins&gt;5&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;,trans&lt;/ins&gt;-13) -dien-1-oic acid&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Common Name=&amp;amp;&amp;amp;15S-15-methyl Prostaglandin F_2 alpha&amp;amp;&amp;amp;(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid&amp;amp;&amp;amp;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Common Name=&amp;amp;&amp;amp;15S-15-methyl Prostaglandin F_2 alpha&amp;amp;&amp;amp;(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid&amp;amp;&amp;amp;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Source=&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Source=&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;!-- diff cache key wikidb:diff:1.41:old-53109:rev-53110:php=table --&gt;
&lt;/table&gt;</summary>
		<author><name>Editor</name></author>
	</entry>
	<entry>
		<id>https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG58&amp;diff=53109&amp;oldid=prev</id>
		<title>Editor: New page: {{Lipid/Header}}  {{Hierarchy|{{PAGENAME}}}}  {{Metabolite |LipidBank=XPR1762 |LipidMaps=LMFA03010080 |SysName=(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (5-cis,13-trans) -dien-1-o...</title>
		<link rel="alternate" type="text/html" href="https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG58&amp;diff=53109&amp;oldid=prev"/>
		<updated>2010-09-15T09:24:02Z</updated>

		<summary type="html">&lt;p&gt;New page: {{Lipid/Header}}  {{Hierarchy|{{PAGENAME}}}}  {{Metabolite |LipidBank=XPR1762 |LipidMaps=LMFA03010080 |SysName=(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (5-cis,13-trans) -dien-1-o...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Lipid/Header}}&lt;br /&gt;
&lt;br /&gt;
{{Hierarchy|{{PAGENAME}}}}&lt;br /&gt;
&lt;br /&gt;
{{Metabolite&lt;br /&gt;
|LipidBank=XPR1762&lt;br /&gt;
|LipidMaps=LMFA03010080&lt;br /&gt;
|SysName=(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (5-cis,13-trans) -dien-1-oic acid&lt;br /&gt;
|Common Name=&amp;amp;&amp;amp;15S-15-methyl Prostaglandin F_2 alpha&amp;amp;&amp;amp;(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid&amp;amp;&amp;amp;&lt;br /&gt;
|Source=&lt;br /&gt;
|Chemical Synthesis=&lt;br /&gt;
|Metabolism=&lt;br /&gt;
|Biological Activity=Intramuscularly injection of 15(S)-15-methyl Prostaglandin F2 alpha  induce abortion.[[Reference:Lindblom_B:Hahlin_M:Kallfelt_B:Hamberger_L:,Lancet,1987,1,776|{{RelationTable/GetFirstAuthor|Reference:Lindblom_B:Hahlin_M:Kallfelt_B:Hamberger_L:,Lancet,1987,1,776}}]] 15(S)-15-methyl Prostaglandin F2 alpha  causes sustained contractions in human vascular smooth muscle tissues (fetal aorta and arterial smooth muscle from chorionic vessels).[[Reference:Word_RA:Kamm_KE:Casey_ML:,J. Clin. Endocrinol. Metab.,1992,75,1027|{{RelationTable/GetFirstAuthor|Reference:Word_RA:Kamm_KE:Casey_ML:,J. Clin. Endocrinol. Metab.,1992,75,1027}}]]15(S)-15-methyl Prostaglandin F2 alpha  shows reduction of serum progesterone and induction of luteolysis in non-pregnant animal.[[Reference:Wilks_JW:,Prostaglandins,1980,20,793|{{RelationTable/GetFirstAuthor|Reference:Wilks_JW:,Prostaglandins,1980,20,793}}]]&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
{{Lipid/Footer}}&lt;/div&gt;</summary>
		<author><name>Editor</name></author>
	</entry>
</feed>